Mees Mosseveld

Erasmus MC, Netherlands

Poster(s):

• (138) The risks of immune- and inflammatory related post-acute sequelae of COVID-19: a network study in 6 European countries, the US, and Korea
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (247) DARWIN EU® - Characterization of Patients with Chronic Hepatitis B and C
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (293) Time trends of prevalence of drugs with suggested shortages in Europe
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (364) The Importance of Standardization in Observed-to-Expected Analysis: Using COVID-19 Vaccine Adverse Event as an Example.
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST